A Novel Prophylaxis Strategy Using Liposomal Vaccine Adjuvant CAF09b Protects against Influenza Virus Disease

A Novel Prophylaxis Strategy Using Liposomal Vaccine Adjuvant CAF09b Protects against Influenza Virus Disease

The SARS-CoV-2 pandemic caused a massive health and societal crisis, although the fast development of effective vaccines reduced some of the impact. To prepare for future respiratory virus pandemics, a pan-viral prophylaxis could be used to control the initial virus outbreak in the period prior to v...

Full description

Bibliographic Details
Main Authors: Julie Zimmermann, Signe Tandrup Schmidt, Ramona Trebbien, Rebecca Jane Cox, Fan Zhou, Frank Follmann, Gabriel Kristian Pedersen, Dennis Christensen
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:International Journal of Molecular Sciences
Subjects:
liposomal adjuvant
virus prophylactic (treatment)
type I IFN
influenza virus
Online Access:https://www.mdpi.com/1422-0067/23/3/1850

Internet

https://www.mdpi.com/1422-0067/23/3/1850

Similar Items